A new study by U.S. researchers suggests that using high-potency chemotherapy in myeloma as part of bridging therapy — medications given before patients are…

The experimental cancer vaccine SurVaxM may improve survival in people with newly diagnosed glioblastoma, an aggressive form of glioma. The therapy’s developer, Mimivax,…

Note: This column describes the author’s own experiences with autologous stem cell transplant. Not everyone will have the same response to treatment. Consult your doctor…